Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Aarti Pharmalabs Ltd

Aarti Pharmalabs Ltd share price and stock overview

Aarti Pharmalabs Ltd (NSE: AARTIPHARM, BSE: 543748) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE0LRU01027 and a face value of Rs 5. As of 01 October 2026, it trades at Rs (953.75) with a market capitalisation of Rs 8825.87 crore. Figures are live and subject to change.

Aarti Pharmalabs Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
953.75 -19.05 (-1.96%) downArrowC
As on: 01-Oct-2026 , 02:49 AM
Market Cap(₹Cr) 8825.87
Book Value(₹Cr) 218.6111288
BSE Code : 543748 NSE Symbol : AARTIPHARM EPS(TTM) : 23.18 ISIN Demat : INE0LRU01027 P/E(TTM) : 41.99 Face Value(₹) : 5 Div & Yield % : 0.36

Today Market

Stock Performance

Today Market

Today's High

73,062.23

Todday's Low

72,366.44

Open at

72,441.15

Previous Close

72,529.07

Volumes

Avg Price

-48.78

Historical Performance

News

28 Sep 26
Aarti Pharmalabs will halt securities trading from October 1, 2026, per SEBI regulations
Aarti Pharmalabs Limited will close its trading window for securities transactions from October 1, 2026, until 48 hours after the announcement of its financial results for the quarter ending September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
31 Aug 26
Aarti Pharma Labs announced the resignation of G.M. Naidu, effective August 31, 2026
Aarti Pharma Labs informed the BSE and National Stock Exchange of India that G.M.
19 Aug 26
Aarti Pharmalabs Ltd fixes record date for Final dividend
Aarti Pharmalabs Ltd fixes record date for Final dividend Record date is 15 September 2026 Aarti Pharmalabs Ltd has fixed 15 September 2026 as record date for payment of final dividend of Rs 2 per equity share of face value of Rs 5 each for FY 2025-26.
18 Aug 26
Aarti Pharmalabs Ltd fixes record date for Final dividend
Aarti Pharmalabs Ltd fixes record date for Final dividend Record date is 15 September 2026 Aarti Pharmalabs Ltd has fixed 15 September 2026 as record date for payment of final dividend of Rs 2 per equity share of face value of Rs 5 each for FY 2025-26.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
30-09-26 983.50 1002.40 943.00 953.75 951362 56867 921938256.75 22620.45
29-09-26 912.00 985.05 906.20 972.80 812673 42698 774399131.90 22716.20
28-09-26 940.00 946.40 910.50 914.00 528118 29840 490363985.95 22780.25
25-09-26 930.00 962.00 915.45 939.55 675198 33528 637306245.45 23140.50
24-09-26 934.50 957.00 923.35 934.25 800441 41353 754620907.80 23063.10
23-09-26 885.00 957.30 885.00 940.10 2945650 117728 2760139164.50 23446.80
22-09-26 862.00 909.50 861.20 883.75 1401079 61760 1246278634.25 23329.00
21-09-26 820.00 871.20 811.20 846.45 2420466 39950 2012385549.85 23414.30
18-09-26 827.00 845.70 812.40 820.40 1901494 22382 1563253137.65 23346.40
17-09-26 811.00 836.00 801.95 826.95 244047 21834 200615155.70 23270.60
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

8825.87

PE Ratio

41.99

PB Ratio

4.45

Dividend Yield

0.36

ROE

9.21

ROCE

11.11

Book Value (₹)

218.6111288

Face Value (₹)

5

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 155737 0.17 155737 1
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 155737 0.17 155737 1
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 5101775 5.63 5101775 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 25690092 28.33 25690092 30
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 7915360 8.73 7915360 9
Others 0 0.00 0 0
Sub Total 38707227 42.69 38707227 47
Total ShareHolding for Promoter & Group 38862964 42.86 38862964 48
plus   Publice Share Holding
plus  Institution
Government(Central / State) 8864 0.01 8864 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1 0.00 1 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7412208 8.17 7412208 101
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4804952 5.30 4804952 2
Mutual Funds / UTI 716967 0.79 716967 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1028579 1.13 1028579 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13971571 15.41 13971571 129
plus  Non Institution
Bodies Corporate 2897566 3.20 2897566 1113
Clearing Members 81594 0.09 81594 39
Directors & their Relatives 26901 0.03 26901 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1529230 1.69 1529230 4917
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1052484 1.16 1052484 2646
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9463596 10.44 9463596 58
Individuals holding nominal share capital up to Rs. 1 lakh 21720729 23.95 21720729 167409
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18492 0.02 18492 6
Others 307660 0.34 307660 3
Sub Total 37845278 41.74 37845278 176329
Total Public Shareholding 51816849 57.14 51816849 176458
Total of Promoter & Public ShareHolding 90679813 100.00 90679813 176506
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 90679813 100.00 90679813 176506

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales1,819.442,115.071,852.611,945.231,199.94
OPM (%)12.9617.0516.2213.4112.95
OP235.72360.69300.49260.77155.38
Other Income9.758.434.902.322.51
PBIDT384.16474.49390.94344.37209.46
INTEREST46.9026.9017.2121.0511.96
PBDT337.26447.59373.73323.32197.50
PBT230.13360.69300.49260.77155.38
EO-2.790.000.000.000.00
PBT after EO232.92360.69300.49260.77155.38
TAXES58.2188.2883.5967.2833.13
PAT174.71272.40216.90193.49122.25
EPS19.2530.0423.9321.3513.49
Raw Material45.6239.5246.3452.1450.94
Power and Fuel4.833.854.543.863.47
Employee Cost9.517.667.476.677.10
Other Manufacturing Expenses0.520.440.450.004.29
Selling and Administration Expenses4.003.214.175.242.28
Miscellaneous Expenses3.331.541.581.710.06
Revenue (Growth %) -13.9814.17-4.7662.110.00
PBIDT (Growth %)-19.0421.3713.5264.41-4,553,563.04
PAT (Growth %) -35.8625.5912.1058.27-2,657,765.22
PBIDT (Margin %)21.1122.4321.1017.7017.46
PAT (Margin %) 9.6012.8811.719.9510.19

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 45.3345.3245.3145.310.250.25
Reserves Total 1937.021798.551576.151393.271238.71-0.02
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.0045.310.00
Total Shareholders Funds1982.351843.871621.461438.581284.270.23
Secured Loans 685.63394.86250.80206.710.000.00
Unsecured Loans 68.7316.6321.150.98327.400.00
Total Debt754.36411.49271.95207.69327.400.00
Other Liabilities47.2122.095.284.660.000.02
Total Liabilities2783.922277.451898.691650.931611.670.25
APPLICATION OF FUNDS :
Gross Block 2129.311653.441472.151303.761100.710.00
Less : Accumulated Depreciation 691.84594.12518.82455.37399.590.00
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 1437.471059.32953.33848.39701.120.00
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress393.08368.70136.92101.90187.370.00
Producing Properties0.000.000.000.000.000.00
Investments 44.0257.0361.6655.4839.870.00
Current Assets, Loans & Advances
Inventories 636.21544.22582.15537.68444.380.00
Sundry Debtors 586.55552.59448.82371.67304.220.00
Cash and Bank Balance6.623.524.430.3756.500.25
Loans and Advances 164.0492.6180.8343.7085.180.00
Total Current Assets1393.431192.951116.23953.42890.270.25
Less : Current Liabilities and Provisions
Current Liabilities 398.29311.96294.06248.26139.350.00
Provisions 11.2210.546.248.3316.460.00
Total Current Liabilities & Provisions409.51322.49300.30256.59155.800.00
Net Current Assets983.92870.45815.93696.82734.470.25
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets14.134.082.311.950.000.00
Deferred Tax Liability148.46123.77100.2470.8059.350.00
Net Deferred Tax-134.33-119.69-97.93-68.85-59.350.00
Other Assets59.7641.6328.7717.188.210.00
Total Assets2783.922277.441898.681650.931611.680.25
Contingent Liabilities7.947.200.340.010.000.00

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 254.63-156.534.4078.63170.58
Investing Activities -133.54-115.55-184.40-418.38-425.14
Net Cash Flow 56.25-56.203.70-1.162.70
Operating Activities -64.84215.88183.69338.58257.26

Peers

Balance Sheet Financial Ratios Profit & Loss
Accent Microcell...

674.65

(+0.10%)
Accretion Pharma...

214.00

(+1.45%)
Achyut Healthcar...

Advanced Enzyme ...

281.60

(-0.19%)
Akums Drugs & Ph...

818.50

(-0.13%)
Albert David Ltd

872.25

(-0.47%)
Alembic Pharmace...

825.45

(-4.18%)
Alivus Life Scie...

1,379.30

(+1.66%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
CVG
Chandrakant V Gogri
Chairman Emeritus
Executive
RCG
Rashesh C Gogri
Chairman(Non Exe)&Dir(Non-Ind)
Executive
HGG
Hetal Gogri Gala
Vice Chairman / Executive Director / MD
Executive
Functional Directors
NJS
Narendra Jagannath Salvi
Executive Director & MD
Exec.
Independent Directors
RVG
Rajendra V Gogri
Non-Exec & Non-Independent Dir
Ind.
PHD
Parimal H Desai
Non-Exec & Non-Independent Dir
Ind.
VGN
Vinay Gopal Nayak
Independent Non Exe. Director
Ind.
BRV
Bhavesh R Vora
Independent Non Exe. Director
Ind.
VGG
Vilas G Gaikar
Independent Non Exe. Director
Ind.
RV
Rupal Vora
Independent Non Exe. Director
Ind.
JS
Jeenal Savla
Independent Non Exe. Director
Ind.
PT
Pradeep Thakur
Independent Non Exe. Director
Ind.
NG
NEHAL GAREWAL
Non-Exec & Non-Independent Dir
Ind.
Company Secretary & Compliance
JM
Jeevan Mondkar
CS / Compliance Officer / Legal Head
Sec.

Frequently Asked Questions

What is the NSE symbol and BSE code for Aarti Pharmalabs Ltd? −

Aarti Pharmalabs Ltd trades on NSE under AARTIPHARM and on BSE under code 543748. The ISIN is INE0LRU01027 and the face value is Rs 5.

What is the share price of Aarti Pharmalabs Ltd today? +

As of 01 October 2026, Aarti Pharmalabs Ltd trades at Rs 953.75, a change of -19.05 (-1.96%) on the day. Prices are live and subject to change.

What is the market capitalisation of Aarti Pharmalabs Ltd? +

As of 01 October 2026, Aarti Pharmalabs Ltd has a market cap of about Rs 8825.87 crore. This figure is live and moves with the share price.

Is Aarti Pharmalabs Ltd profitable? +

In March 2026, Aarti Pharmalabs Ltd reported a profit after tax of Rs 174.71 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Aarti Pharmalabs Ltd? +

: As of 01 October 2026, the PE (TTM) for Aarti Pharmalabs Ltd is 41.99 and the price-to-book ratio is 4.45. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Aarti Pharmalabs Ltd pay a dividend? +

As of 01 October 2026, the dividend yield for Aarti Pharmalabs Ltd is 0.36%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Aarti Pharmalabs Ltd? +

As of the latest disclosed pattern, promoters hold 42.86% of Aarti Pharmalabs Ltd. Public shareholding is 57.14%, including mutual funds at 0.79% and foreign institutional investors at 8.17%.

What were the latest annual financials of Aarti Pharmalabs Ltd? +

In March 2026, Aarti Pharmalabs Ltd reported net sales of Rs 1,819.44 crore, revenue growth of -13.98%, and earnings per share of Rs 19.25.